ArticleCell death & disease2025

Targeted demethylation of the EphA7 promoter inhibits tumorigenesis via the SP1/DNMT1 and PI3K/AKT axes and improves the response to multiple therapies in cervical cancer.

Wenfan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.